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Abstract 
Arterial stiffness is considered both a risk factor and indicator of cardiovascular 
disease. The purpose of this study was to examine the associations of cardiovascular risk 
indicators of arterial compliance among 226 black and white individuals enrolled in an 
outpatient clinical setting. Data were collected by survey and examination with a 
computerized arterial pulse waveform analyzer. Arterial stiffness was estimated by 
indirect estimates of small artery and large artery compliance, as well as pulse pressure. 
After adjustments for age, race, and gender, logistic regression identified hypertension, 
end organ damage, and ovenveight as the strongest predictors for the three arterial 
stiffness indices. The results of this study identified similar factors associated with each 
of the different noninvasive measures of arterial stiffness. 
Keywords: arterial compliance, pulse pressure, cardiovascular disease 
Abbreviations: 
CVD - Cardiovascular Disease 
C 1 - Large arterial elasticity 
C2 - Small arterial elasticity 
HDI - Hypertension Diagnostics, Inc 
LAEI - large artery elasticity index 
SAEI - small artery elasticity index 
PP - pulse pressure 
BP - blood pressure 
BMI - body mass index 
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One of the leading causes of mortality and a significant risk factor for 
Cardiovascular Disease (CVD) is the progression of atherosclerosis. Atherosclerosis 
includes the degenerative hardening of the arteries due to cholesterol-laden plaque 
accumulation narrowing the arterial wall, causing loss of elasticity. The loss of arterial 
elasticity and enhanced wave reflection are considered to be both markers of and an 
independent risk factor of CVD, suggesting a focus on arterial wall health in the 
prevention and treatment of this disease (Cohn J, 2001; Southerland et al. 2000; Van 
Doormnum et al. 2003). The transformation in arterial wall elasticity can be monitored 
and may help identify at risk patients and improve therapeutic decision making, due to 
slow progressive changes in the viscoelastic properties of the arterial wall long before the 
onset of disease symptoms (London G and Cohn J, 2002; Taal et aL 2007). 
Arterial compliance is a measure of the storage capability of the blQod vesseL 
Presently there is no "gold standard" to measure vessel compliance; most of the methods 
used in previous years have been invasive techniques, which are not ideal in the clinical 
setting. A developing and novel approach is the assessment of arterial pressure 
waveform, a technique based on noninvasive measurements of pulse contour analysis 
which allows the estimation of arterial elasticity and flexibility (Resnick et aL 2000). 
A more traditional indirect measurement of arterial stiffuess is the pulse pressure 
width, which is thought to be a cardiovascular risk factor in itself (Alderman et al. 1998; 
Arnett et al. 1994). Pulse pressure is the difference between the systolic and diastolic 
blood pressures, and is dependent on cardiac output, large arterial elasticity, and wave 
reflection (Nichols W, 2005; Syeda et al. 2003). Wide pulse pressures are markers of 
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increased vascular stiffness due to the loss of elastic recoil mechanism in the aorta; often 
occurring linearly with age (Burt et al. 1995). 
Arterial stiffness is a predictor of cardiovascular events independent of traditional 
risk factors such as hypertension, diabetes, hypercholesterolemia, and stroke (Roman et 
al. 2005). The associations of arterial stiffness and disease outcome may be due to both a 
clinical and biological mechanism. However, it is unclear if disease progression can be 
attributed to the estimates determined from these non-invasive measures.. This study 
includes measurements of small and large arterial stiffness as well as a traditional 
measure of pulse pressure in individuals with varying degrees of di~ease of end organ 
disease. 
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Historical Overview 
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in 
the US, affecting more than 80 million Americans each year, and costs this country 
approximately $350 billion per year (AHA). One of the main risk factors for CVD is the 
progression of atherosclerosis (Elter, JR, et aI., 2006). Atherosclerosis is the 
degenerative hardening of the arteries due to cholesterol-laden plaque accumulation, 
narrowing the arterial wall, causing loss of elasticity. Inflammation is a key component 
of atherosclerosis and vascular endothelial cell damage due to the production of 
circulating cytokines (Van DoomuID, et ai, 2003). Atherosclerosis is a slow progressive 
disease that does not have immediate symptoms and thus many at risk individuals are 
unaware of their disease state. Often the first indicator of this disease is a fatal acute 
myocardial infarction (Naghavi et aI, 2006). 
The arterial wall consists of three layers: the intima, media, and adventitia. The 
intima is the inter-most surface of the arterial wall and is comprised mainly of endothelial 
cells, which nonnally resist adhesion of monocytes. When the endothelial cells are 
compromised they promote attachment of leukocytes due to the over expression of 
adhesion molecules, such as Vascular adhesion molecule-l (VCAM-l), interleukin-l (IL-
l), and tumor necrosis factor-a (TNF- a); which binds leukocytes that are found in the 
composition of plaque. This process is highly influential in the progression of 
inflammation. These monocytes migrate through the intima and mature into 
macrophages, which causes accumulation of cholesterol esters, forming foam cells 
producing a fatty streak. The media is comprised of smooth muscle cells (SMC), elastin, 
and collagen fibers, which are ultimately responsible for vessel constriction. Early stages 
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of atherogenesis leads to the development of 'complex plaque' due to the migration of 
SMC from the media to the intima, where fibro-lipid lesions are produced in the intima 
forming fibrous cap and necrotic core. The outer-most layer, adventitia, is comprised of 
fibrous connective tissue which maintains the vessel shape. Physical disruption of the 
lesion causes thinning and fracturing of the fibrous cap causing plaque rupture which 
leads to thrombus formation (Paquette et aI, 2000; Augst et al 2007; Hashimoto et al 
1999; Beck et al 2005; Booth et aI, 2004). 
Studies suggest that chronic inflammatory diseases and conditions may lead to an 
increased procoagulant state in the peripheral blood; which suggests that the same 
"systemic" markers associated with various vascular disease states may also be 
associated with cardiovascular disease and causally with atherosclerosis, myocardial 
infarction, stroke, and thrombosis (Loos, BG et ai, 2005). These similar parameters may 
be involved with the atherosclerosis process in different organs throughout the body. 
Therefore, we can attempt to conclude that these same markers found in the peripheral 
blood may provide a biologically plausible explanation to the epidemiological link 
between chronic blood diseases (Loos, BG, et ai, 2005). The loss of arterial elasticity 
and enhanced wave reflection are not only thought to be markers ofCVD, but also an 
independent risk factor for CVD, suggesting a focus on arterial wall health in the 
prevention and treatment of CVD (Cohn IN et aI, 2001; Southerland JH, et ai, 2006). 
The loss of arterial elasticity and enhanced wave reflection are due to the 
pathophysiological changes in the blood vessel, affecting vascular endothelial function of 
both the small and large arteries leading to a reduction in arterial compliance which is 
known to be associated with numerous cardiovascular events (Glasser et al 1997). This 
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transfonnation in arterial wall elasticity can be monitored and may help identifY at risk 
patients and improve therapeutic decision making~ due to slow progressive changes in the 
viscoelastic properties of the arterial wall long before the onset of disease symptoms 
(Glasser et aI, 1997). 
Vascular wall dynamics can be examined in a variety of ways. Arterial stiffness 
refers to resistance in deformation of the vessel wall .. Arterial compliance is a measure of 
the storage capability of the blood vessel, and is defined as absolute change in volume, 
diameter, and area per change in pressure. Another common assessment is arterial 
distensibility which is the percent change in arterial compliance. Distensibility allows 
one to compare vessels of different sizes. Lastly, arterial elasticity, based on elastic 
modulus, describes the change in stress, or force per unit area, for a given change in 
strain, the ratio of change in area to the initial area. This measurement is independent of 
size and shape, and is used to assess vessel stiffness (Glasser et ai, 1997). 
Presently there is no "gold standard" to measure arterial compliance. Most of the 
methods used in previous years have been invasive techniques, which are not ideal in the 
clinical setting. There are three suggested mechanism to measure both large and small 
arterial compliance; which include last systolic pressure augmentation, biopsy of an 
isolate section of the small artery, and recently and most importantly assessing the arterial 
pressure wavefonll. This technique is based on a noninvasive measurement of pulse 
contour analysis which allows estimation of arterial elasticity and flexibility (Resnick et 
al 2000; Finkelstein et ai, 1988). 
The HDIlPulsewave CR-2000 Research Cardio Vascular Profiling System, 
(Hypertension Diagnostics, Inc, Eagan, Minnesota., USA, 2001) can be used to evaluate 
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arterial compliance through a computerized arterial pulse waveform analysis, that 
calculates the diastolic decay of the pulse wave, which allows for inferences of 
vasculature resistance along with stroke volume ejection and systemic vascular resistance 
in the arterioles (Syeda et aI, 2003; Nichols, 2005). This user friendly device computes 
arterial compliance by measuring response voltage from applied mechanical stress and/or 
strain over an electric field over the radial artery. The best possible explanation of 
waveform analysis is based on the modified Windkessel model in electrical terms 
(Glasser et al. 1997) (Figure 1). This model has two main parallel components, a resistor 
and a capacitor, representing the small and large arterial compliance, which is connected 
to a voltage source. This voltage source represents the left ventricle of the heart, which 
conducts blood flow into the system during systole creating proximal arterial pressure in 
the large vessels. This pressure is considered the pulsatile flow which defines the 
forward and reflecting waves due to stroke volume ejection into the aorta which is 
dependent on the compliance of the artery. This computerized method uses the arterial 
pressure to estimate capacitive compliance in the aorta, which represents the central 
determinant of systemic arterial compliance (SAC), C 1, and is therefore a marker for 
large arterial stiffness. The interance element represents the inertia of the blood to the 
smaller blood vessels, where the oscillatory compliance is measured representing the 
distal pressure of the continuous, steady state flow across the small arteries. The brachial 
artery is the detennjnant of the peripheral arterial compliance (PAC), C2, and therefore is 
a marker for small artery elasticity (SAE). These measurements are collectively 
considered the diastolic decay of the pulse wave, which allow for inferences of 
vasculature resistance along with stroke volume ejection and systemic vascular resistance 
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(SVR) in the arterioles (Cohn et aI, 2001; Glasser et al~ 1997; Syeda et ai, 2003; Nichols~ 
2005). 
A more traditional indirect measurement of arterial stiffness is the pulse pressure 
width, which is thought to be a cardiovascular risk factor in itself.. Pulse pressure is the 
difference between the systolic and diastolic blood pressure, and is dependent on cardiac 
output, large arterial elasticity, and wave reflection. Arterial stiffness due to structural 
changes in the arterial walls causes an increase in pulse wave velocity, and thus an 
increase in pulse pressure (Roman, MJ et af., 2005) .. This increase in pulse pressure is 
due to the decrease in diastolic blood pressure which leads to myocardial ischemia and 
CVD. Systolic blood pressure increases linearly with age; however, diastolic blood 
pressure increases until around the age of 55, and then begins to decrease. This is due in 
part!, to the loss of compliance, leading to a widening of the pulse pressure. Systolic 
hypertension and widen pulse pressure are markers of increased vascular stiffness due to 
the loss of elastic recoil mechanism in the aorta. When this loss occurs, the full stroke 
volume delivery through the resistance arterioles occurs during systole, instead of 
through a smooth steady flow throughout diastole .. This widening effect of pulse pressure 
is a predictor of cardiovascular events (Burt et aI, 1995). 
Reduction in arterial compliance leads to a disproportionate increase in systolic 
blood pressure in the ascending aorta (Nichols, \\TN, 2005).. Decreased compliance has 
two main adverse effects on central circulation: First the aorta stiffens and a blood 
injection from the left ventricle generates a pressure wave. The amplitude of this pulse 
pressure is higher in the aorta than in the left ventricle due to increased impedance. 
Second, there is an increase in systolic pressure due to early wave reflection causing a 
12 
decrease in diastolic blood pressure. (Rietzschel, ER et ai, 2001). Both the systolic and 
pulse pressures become increased due to an alteration in the timing of reflected waves 
(Roman, MJ et al., 2005). This ultimately causes an increase in arterial pressure wave 
velocity which is an indicator of arterial stiffness (Vlachopoulous, C et ai, 2005). 
Arterial stiffness is a predictor of cardiovascular events independent of traditional 
risk factors such as hypertension, diabetes, hypercholesterolemia, and smoking (Roman, 
MJ et ai., 2005). The relationship between atherosclerosis and inflammation is quite 
evident according to the current literature, it was also suggested by Yasmin et al. that 
elevated levels of inflammatory mediators may be strongly associated with arterial 
stiffening. This study reported that C-reactive protein may be independently related to 
higher pulse wave velocity and pulse pressure which are known surrogates of loss of 
arterial elasticity (Yasmin, MCM, et al., 2004). 
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Contemporary Related Studies 
Current literature suggests both a clinical and biological causal mechanism may 
exist to explain the potential association between chronic systemic diseases and 
cardiovascular disease progression. However, current evidence is insufficient to support 
the idea that systemic inflammation is an individual risk factor for cardiovascular disease. 
It is important to study the interrelationship between end organ diseases due to the large 
volume of people who are simultaneously, chronically affected by multiple inflammatory 
diseases. Even a small association between disease states would be vital information for 
the dental, diabetic, and especially the cardiovascular disease community_ There are 
many phannacological and non-pharmacological therapies available to prevent and 
reduce the severity of atherosclerosis and the events associated with CVD. 
Some studies suggest that males have a higher burden of cardiovascular disease 
events as well as a higher burden of other blood related diseases, such as periodontal 
disease (Desvarieux, Met ai, 2004). Thus, it is important to examine gender differences, 
along with possible race and/or ethnic differences when studying the relationship 
between systemic diseases and atherosclerosis. When examining the Atherosclerosis 
Risk In Communities (ARIC) study population, the investigators suggest that estrogen 
may playa protective role against vessel stiffness in premenopausal women. When 
compared to postmenopausal women, premenopausal women had less arterial stiffness, 
even when compared to men of the same age range (Arnett et aI, 1994; Glasser et al 
1997).. Benetos et al showed that women tend to have a 5-10% lower stiffness than men 
of the same age. 
14 
Atherosclerotic progression occurs with the aging process, but the rate is 
accelerated with comorbid condition including high blood pressure, high cholesterol, 
smoking, and diabetes. Nearly all studies measuring vascular stiffness and reduced 
compliance have shown age as an intrinsic component of increase stiffness (Weinberger 
et aI, 2002). Benetos et ai, demonstrated this in subjects over the age of 50, in which a 
rapid increase in SBP and decrease in compliance was discovered, along with a plateau 
effect of the DBP; which continually decreased with age. Additional studies showed that 
with each decade increase in age, arterial stiffness increases by approximately 10-15% 
after the age of lOin both males and females (Benetos et ai, 2002). 
Hypertensive individuals have stiffer, less compliant arteries than normotensive 
individuals (Beck, JD et ai, 2005). The adverse effect of hypertension results in 
ventricular hypertrophy of the medial layer. In younger hypertensive patients, elevated 
BP does not affect the vasculature width in the radial artery, however, in central arteries 
the width increases propo~ionately with BP levels. In elderly hypertensive populations, 
arterial stiffening is primarily due to the development of plaque in the arteries 
independent ofBP levels. Even in elderly hypertensives, vessel width only changes in 
the central arteries. In the Hypertension Detection and Follow-up Program, Alderman et 
al found elevated relative risk of 5-yr mortality with DBP, SBP, and pulse pressure in this 
hypertensive population. Even after adjusting for additional covariates, pulse pressure 
was found to be a significant predictor of overall mortality and is considered an 
independent predictor of cardiovascular disease events. (London et ai, 2002). The 
Framingham study also depicted pulse pressure as a strong predictor of CVD more 
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specifically of myocardial infarction in both hypertensives and normotensives (Benetos et 
al, 1997; Benetos et aI, 1998). 
Fasting glucose is also known to be highly associated with arterial stiffness, 
proportionately with level of blood glucose, even among normal healthy subjects. 
Hyperglycemia is a common factor for both Type 1 and Type 2 diabetic individuals, and 
has been shown to be associated with an increase in arterial stiffness when compared to 
non-diabetic individuals, even though many other factors including disease duration and 
degree of therapy control are thought to influence this affect as well. 
In vitro studies have shown a link between arterial stiffness and 
hypercholesterolemia along with clinical studies suggesting a significant positive 
correlation between cholesterol and low-density lipoprotein cholesterol (LDL), and a 
negative correlation with high-density lipoprotein cholesterol (HDL) with arterial 
stiffness. Familial hypercholesterolemia has also been shown to be associated with the 
stiffening of the arterial wall; which implies possible genetic and environmental 
components may play an essential role in the development of arterial stiffness and 
atherosclerosis. 
Additional studies have shown impaired arterial flexibility especially in the aortic, 
carotid., iliac, and brachial arteries in patients with congestive heart failure (CHF). 
Arterial stiffness has been shown to be causally related to increase of SBP and pulse 
pressure in patients with End-stage Renal Disease (ESRD) and is an independent risk 
factor for CVD related morbidity and mortality (Benetos et aI, 2002). 
Cigarette smoking is another known risk factor for atherosclerosis accelerating 
endothelial damage., possibly due to inhibited basal and nitric oxide (NO) production. 
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Cigarette smoking elevates blood pressure levels even at an acute level, and has been 
shown to decrease arterial compliance in both normotensives and hypertensive smokers 
compared to non-smokers. 
Exercise has been shown to be associated with arterial compliance, but only in a 
few studies; in which they illustrated exercise training caused an increase in arterial 
compliance contributed to enhanced maximal oxygen consumption (Glasser et aI, 1997). 
17 
Significance 
The relationship of atherosclerosis and "systemic" disease is unclear particularly 
among whites and blacks. This study implements a novel measurement of arterial 
stiffness as well as a traditional measure of pulse pressure in a dental health population 
with individuals with varying degrees of disease of different organs throughout the body. 
The results can be used to identify common factors in the mechanism of atherosclerosis 
as well the results will identify dental, diabetic, endocrine, and hypertension professionals 
as an important component of cardiovascular disease prevention. This study will assign 
the risks of multiple indicators of arterial stiffness with hypertension, 
hypercholesterolemia, end organ damage, and overweight in black and white men and 
women. Early detection of atherosclerotic markers in high risk individuals may prove to 
be opportunistic in identifying cardiovascular events that may also be progressing along 
with other comorbid diseases (Morrison et ai, 1995). 
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Abstract 
Arterial stiffness is considered both a risk factor and indicator of cardiovascular 
disease. The purpose of this study was to examine the associations of cardiovascular risk 
indicators of arterial compliance among 226 black and white individuals enrolled in an 
outpatient clinical setting. Data were collected by survey and examination with a 
computerized arterial pulse wavefonn analyzer. Arterial stiffness was estimated by 
indirect estimates of small artery and large artery compliance, as well as pulse pressure. 
After adjustments for age, race, and gender, logistic regression identified hypertension, 
end organ damage, and overweight as the strongest predictors for the three arterial 
stiffness indices. The results of this study identified similar factors associated with each 
of the different noninvasive measures of arterial stiffuess. 
Keywords: arterial compliance, pulse pressure, cardiovascular disease 
Abbreviations: 
CVD - Cardiovascular Disease 
C 1 - Large arterial elasticity 
C2 - Small arterial elasticity 
HDI - Hypertension Diagnostics, Inc 
LAEI - large artery elasticity index 
SAEI - small artery elasticity index 
PP - pulse pressure 
BP - blood pressure 
BMI - body mass index 
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Introduction 
One of the leading causes of mortality and a significant risk factor for 
Cardiovascular Disease (CVD) is the progression of atherosclerosis. Atherosclerosis 
includes the degenerative hardening of the arteries due to cholesterol-laden plaque 
accumulation narrowing the arterial wall, causing loss of elasticity. The loss of arterial 
elasticity and enhanced wave reflection are considered to be both markers of and an 
independent risk factor of CVD, suggesting a focus on arterial wall health in the 
prevention and treatment of this disease [Cohn J, 2001; Southerland et a1. 2000; Van 
Doonnnum et al. 2003]. The transformation in arterial wall elasticity can be monitored 
and may help identify at risk patients and improve therapeutic decision making, due to 
slow progressive changes in the viscoelastic properties of the arterial wall long before the 
onset of disease symptoms [London G and Cohn J, 2002; Taal et a1. 2007]. 
Arterial compliance is a measure of the storage capability of the blood vessel. 
Presently there is no 4'gold standard" to measure vessel compliance; most of the methods 
used in previous years have been invasive techniques, which are not ideal in the clinical 
setting. A developing and novel approach is the assessment of arterial pressure 
waveform, a technique based on noninvasive measurements of pulse contour analysis 
which allows the estimation of arterial elasticity and flexibility [Resnick et al.. 2000]. 
A more traditional indirect measurement of arterial stiffness is the pulse pressure 
width, which is thought to be a cardiovascular risk factor in itself[Aldennan et al. 1998; 
Arnett et al. 1994]. Pulse pressure is the difference between the systolic and diastolic 
blood pressures, and is dependent on cardiac output, large arterial elasticity, and wave 
reflection [Nichols W, 2005; Syeda et a1. 2003]. Wide pulse pressures are markers of 
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increased vascular stiffness due to the loss of elastic recoil mechanism in the aorta; often 
occurring linearly with age [Burt et aL 1995]. 
Arterial stiffuess is a predictor of cardiovascular events independent of traditional 
risk factors such as hypertension, diabetes~ hypercholesterolemia, and stroke [Roman et 
a1. 2005]. The associations of arterial stiffness and disease outcome may be due to both a 
clinical and biological mechanism" However, it is unclear if disease progression can be 
attributed to the estimates determined from these non-invasive measures. This study 
includes measurements of small and large arterial stiffness as well as a traditional 




This study is a cross-sectional assessment of 226 subjects from a dental health 
clinic at the Medical University of South Carolina, as well as a local independent 
retirement community. All data were previously collected infonnation from health 
surveys and pulse contour analysis" The 33 question self-report survey was conducted by 
an interviewer which included demographic information, socioeconomic status 
infonnation, and medical history. 
Measurements of Arterial Compliance 
This study includes three measurements that estimate arterial stiffness in black 
and white men and women "",jth varying degrees of CVD related risk factors, including 
hypertension, hypercholesterolemia, and body mass index (BMI).. The HDIlPulsewave 
CR .... 2000 Research Cardio Vascular Profiling System, (Hypertension Diagnostics, Inc, 
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Eagan, Minnesota, USA, 2001) was used to evaluate arterial compliance through a 
computerized arterial pulse waveform analysis, that calculates the diastolic decay of the 
pulse wave, which allows for inferences of vasculature resistance [Finkelstein et al. 1991; 
Zimlichman et al. 2005]. Arterial compliance is defined as absolute change in volume, 
diameter, and area per change in pressure. This computerized model uses arterial 
pressure to estimate capacitive compliance in the aort~ which represents the central 
determinant of systemic arterial compliance, C 1; and is therefore a marker for large 
arterial stiffness (LAEI). Oscillatory compliance is measured in the brachial artery, the 
detenninant of the peripheral arterial compliance~ C2; and is thus a marker for small 
artery stiffness (SAEI). The best possible explanation of wavefonn analysis is based on 
the modified Windkessel model [Glasser et aL 1997]. 
Cardiovascular profile measurements were taken with the subject in supine 
position from the upper right ann by a blood pressure cuff and left radial artery by a pulse 
pressure sensor. 
Large Arterial Elasticity Index (LAEI), Small Arterial Elasticity Index (SAEI}, 
and Pulse Pressure (PP) were used to compare those with and without cardiovascular 
related risk factors, including hypertension, hypercholesterolemia, end organ damage, 
and being overweight. The distribution of the data was examined and subjects were 
considered to be 'high risk' for reduced arterial compliance if they were included in any 
of the three upper quartiles ofLAEI, SAEI, or PP. An Arterial Stiffuess Score of 0-3 was 
assigned to each subject based on the number of upper quartiles in which the subjects 
were stratified. 
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Subjects were considered to have end organ damage if they had a history of 
diabetes, stroke, heart disease, myocardial infarction, kidney disease, or lung or leg vein 
blood clots. 
Cardiovascular disease risk was also detennined from systolic BP, diastolic BP, 
body mass index (BMI), pulse pressure (PP), and mean arterial blood pressure. 
Data Management and Statistical Analysis 
Data are reported as frequencies for categorical variables and means ± standard 
deviation for continuous variables. Pearson's Correlations were used for continuous 
variables and Chi-squared proportions were used for categorical variables to compare risk 
factors and hemodynamic parameters. Multivariable cross-sectional modeling using 
binary logistic regression was used to estimate odds ratios and 95% confidence intervals 
for CVD outcomes by Arterial Stiffness Score categories. Statistical analyses were 
conducted using SAS analysis software, and were considered statistically significant at 
the .05 level. 
Results 
Compliance Measurements 
Assessments were completed on 226 dental clinic subjects. The compliance 
parameters in relation to risk factors and demographic characteristics of the subjects are 
provided in Table 1. The mean Large Arterial Elasticity Index (LAEI) was 13.4 ± 5.35 
mL/mmHg x 10, mean Small Arterial Elasticity Index (SAEI) was 4.9 ± 3.9 mL/mmHg x 
100, mean pulse pressure (PP) was 60.8 ± 25.9~ and the mean age was 60.5 ± 15.6 in the 
total study cohort. No differences in LAEI, SAEI, or PP were detected between white 
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and black subjects, between subjects with and without hypercholesterolemia, or between 
smokers and non-smokers (Table 1). 
Female subjects had significantly greater reductions in both LAEI (p <.0001) and 
SAEI (p = .002) but no difference in PP when compared to male subjects. Subjects with 
BMI greater than 25 were found to have significantly reduced LAEI (p = .004). Whereas 
subjects with end organ damage had significantly reduced LAEI (p ~ .01) and SAEI (p = 
.007) (Table 1). 
Patients older than 60 years of age showed a significant reduction in LAEI (p 
<.0001), SAEI (p <.0001), and PP (p = .02). It is known that the arterial elastic recoil 
function is reduced significantly after the age of 60 and thus we would expect to see a 
reduction in the small and large arterial compliance as well as with pulse pressure 
measurements due to this age-related physiological change in vessel function [Izzo J and 
Black H, 1999]. Subjects with hypertension also showed a significant reduction in LAE 
(p <.0001) and SAE (p <.0001), and a slight reduction in PP (p = .09) when compared to 
subjects without hypertension (Table 1). 
LAEI and SAEI compliance parameters were highly statistically correlated (p 
<.0001) with a Pearson's correlation coefficient 0[0.358 (-0.095, 0.164). This was to be 
expected because both the small and larger arterial elasticity indices were measured using 
the same mechanism on two different vessels. The LAEI and PP parameters were 
inversely correlated (p = 0.04) with a Person's coefficient of - 0.141 (-0.266, -0.011). As 
the large arteries become more rigid the pulse pressure increases, resulting in an inverse 
relationship between these two parameters. However, the SAEI and PP parameters were 
not significantly correlated. 
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Each of the 226 participants was assigned an arterial stiffness score based on 
placement in upper quartiles of the three arterial stiffness indices. Over half (57 .. 5%) of 
the participants had a score of 0 (Table 2). The prevalence decreased with each score 
category, 22.1 % with a score of 1, 11.1 % with a score of 2 and 9.3% with a score of 3 
(Table 2). 
Associations with Level of Vessel Disease 
(Arterial Stiffness Score) 
Table 3 presents the association of age, gender, race, and arterial stiffness score 
with hypertension, hypercholesterolemia, end organ damage, and overweight. Age was 
significantly associated with hypertension, hypercholesterolemia, and end organ damage 
with greatest risk in age greater than or equal to 60 years. Males and blacks were 
significantly more likely to be overweight than their female and white counterparts" 
Hypertension and end organ damage increased significantly with arterial stiffuess score. 
The crude and adjusted odds ratios for hypertension~ hypercholesterolemia, end 
organ damage, and overweight by arterial stiffness score are presented in table 4. No 
significant patterns were detected by the adjusted model. However, significant odds 
ratios were identified for hypertension and end organ damage for arterial stiffness score 
of2. 
Discussion 
This cross-sectional study compared three indicators of vascular compliance 
estimated from non-invasive measurements with the calculations of a risk score based on 
the upper quartile in the three measures. Over half of the subjects had a score of 0, with 
42.5% having a score of 1 or greater. While the majority of the study population was 
over 60 years of age and had one or more cardiovascular disease risk factors and end 
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organ damage, less than 10% had a score of 3. When comparing SAEI, LAEI, and PP as 
continuous measures, SAEI and LAEI were found to be significantly correlated with each 
other. This would be expected as both measures were estimated from the same pulse 
wave analysis. However, PP, also estimated from the same measurement was not 
associated with either SAEI or LAEI. 
The analyses in this study identified similar factors associated with the three 
indicators of arterial stiffness. Age and hypertension were significantly associated with 
the highest risk measurements with each of the three. End organ damage and gender 
were associated with SAEI and LAEI but not with PP. The higher rates of stiffer arteries 
among women are consistent with other studies in that women tend to have a 5-10% 
lower stiffness than men of the same age [Benetos et al. 2002]. 
Atherosclerotic progression occurs with the aging process, but the rate is 
accelerated with comorbid conditions. Nearly all studies measuring vascular stiffness 
and reduced compliance have shown age as an intrinsic component of increase stiffness 
[Weinberger et al. 2002]. Benetos et al demonstrated with each decade increase in age, 
arterial stiffness increases by approximately 10-15% after the age of lOin both males and 
females [Benetos et al. 2002]. We found significant associations between advanced 
vessel disease and age, especially among subjects greater than 60 years of age. 
Hypertensive individuals have stiffer, less compliant arteries than normotensive 
individuals [Beck J and Offenbacher S, 2005; Benetos et al. 1997; Benetos et al. 1998]. 
In elderly hypertensive populations, arterial stiffening is primarily due to the loss of 
elastic recoil function in the arteries. In this study we found hypertension, end organ 
damage, and being overweight to be associated with arterial compliance estimates and 
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with Arterial Stiffness Score. After adjusting for age, sex and race, significant odds 
ratios for hypertension and end organ damage were only detected for individuals with a 
score of2. 
There are several limitations in this study. First, the information collected was 
from a self-report interviewer survey, which may have biased some of the parameters 
recorded, such as smoking status and diabetes.. In addition, the drug and treatment 
infonnation collected in this study was not complete or reliable. 
The three indicator assessed arterial stiffness differently and at different parts of 
the body_ One might expect different values given disease progression may be different. 
For example, disease progression and arterial compliance might be different in the small 
arteries as opposed to the large arteries and pulse pressure.. Thus, disease might be 
detected earlier in the small arteries. However, these assessments did not detect such 
differences. 
Early detection of atherosclerotic markers in high risk individuals may prove to be 
opportunistic in identifying cardiovascular events that may also be progressing along 
with other comorbid diseases [Morrison et al. 1995]. 
Conclusions 
The three different indicators of arterial compliance had similar factors associated 
with the measurements. Likewise, the associations with disease outcomes were similar 
for the three measures. The arterial stiffness score summing the highest risk group was 
associated with the highest disease risk. These results identify one of the three 
assessments of arterial stiffness are associated with increased disease risks. However!' the 
analyses failed to identify anyone of the three measures as superior in predicating 
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disease. As the three indicators were detennined from one measurement, each marker 
should be correlated. Future longitudinal studies are needed to detennine if SAEI or 
LAEI is an independent predictor of CVD. Such studies should include measures of 
arterial stiffness prior to end-organ damage with follow-up. 
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Table 1. Compliance parameters in relation to CVD risk factors (N = 226) 
CVD Risk Factors LAEI SAEI pp 
Age> 60 (n =119) 11.6 ± 5~1 3.5 ± 2.1 64.7 ± 14.3 
Age < 60 (n =107) 15.5 ± 4.9 6.4 ±4.8 56.3 ± 34.0 
P value <.0001 <.0001 0.02 
Men (n = 99) 15.6 ± 4.6 5.8 ± 3.6 61.7 ± 35.4 
Women (n = 127) 11.8 ± 5.3 4.1 ± 4.1 60.0 ± 14.8 
Pvalue <.0001 0.002 NS 
White (n = 184) 13.4 ± 5.4 4.9 ± 4.1 61.1 ± 27.8 
Black (n = 41) 14.0 ± 5.0 4.7± 3.1 58.4 ± 13.3 
Pvalue NS NS NS 
Hypertension (n = 107) 11.9 ± 5.2 3.8 ±2.4 63.8 ± 13.5 
Not Hypertensive (n = 119) 14.9 ± 5.1 5.8±4.7 58.0 ± 33.1 
P value <.0001 <.0001 0.09 
Hypercholesterolemia (n = 98) 13.3 ± 5.7 4.5 ±2.7 61.9 ± 13.3 
Not Hypercholesterolemia (n = 128) 13.6±5.1 5.1 ± 4.6 60.1 ± 32.4 
P value NS NS NS 
End Organ Damage (n = 84) 12.3 ± 4.9 3.7 ± 2.1 63.2 ± 14.7 
Not End Organ Damage (n = 142) 14.1 ± 5.5 5.5 ±4.6 59.3 ± 30.6 
P value .01 .007 NS 
BMI ~ 25 (n = 160) 14.1±5.5 4.9 ±3.0 61.6 ± 29.5 
BMI < 25 Cn = 66) 11.9 ± 4.6 4.8 ± 5.5 58.6 ± 13.4 
P value 0.004 NS NS 
Smoker (0 = 9) 15.2 ± 4.0 5.9 ± 3.4 57.0 ± 6.7 
Non-smoker (n = 217) 13.4 ± 5.4 4.8±4.0 60.9 ± 26.3 
Pvalue NS NS NS 
SAEI- small arterial elasticity index (in mUmmHg x IOO)~ LAEI = large arterial elasticity index (in mUmmHg x 10); 
pp;= pulse pressure mmHg; NS = not significant~ determined by Pearson's correlationp-value. 
Table 2. Percentages of risk groups by Arterial Stiffness Score 
Arterial Stiffness Upper Quartiles Total Study Total Study 
Score (N=226) % 
0 None 130 57.5 
LAE 16 7.0 
1 SAE 24 10.6 
pp 10 4.4 
LAE*SAE 13 5.8 
2 LAE*PP 6 2.7 
SAE*PP 6 2.7 
3 LAE*SAE*PP 21 9.3 
LAE = large arterial elasticity index; SAE = small arterial elasticity~ PP = pulse pressure~ 
* = mUltiple upper quartHes. 
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Table 3. Distributions of CVD Outcomes by Arterial Stiffness Score, age, gender, and race. (N=226) 
CVD Outcomes 
Hyper- End Organ 
Model Total Study Hypertension cholesterolemia Damage Overweight 
Covariates 226 (100 f.llo) 107 (47%) 98 (430/0) 84 (37%) 160 (71O/f.l) 
Age 
2:: 60 119(53%) 78 (66%) 60 (50%) 63 (53%) 81 (68%) 
<60 107 (47%) 29 (27%) 38 (36%) 21 (20%) 79 (74%) 
p-value <0.0001 0.024 <0.0001 0.34 
Gender 
Male 99 (44%) 46 (47%) 50(51%) 38 (38%) 77 (78%) 
Female 127 (56%) 61 (48%) 48 (38%) 46 (360/0) 83 (65%) 
p-value 0.82 0.056 0.74 0.042 
Race 
White 184 (81%) 83 (45%) 75(41%) 71 (39%) 121 (66%) 
Black 41(18%) 23 (56%) 22 (54%) 12 (29%) 38 (93%) 
p-value 0.20 0.13 0.26 0.0006 
Score 
0 130 (58%) 46 (34%) 56 (43%) 36 (28%) 101 (78%) 
1 50 (22%) 26 (52%) 21 (420/0) 19 (38%) 32 (64%) 
2 25(11%) 20 (80%) 8 (32%) 19 (76%) 15 (60%) 
3 21 (90/0) 15(71%) 13 (62%) 10 (48%) 12 (57%) 
p-value <0.0001 0.23 <0.0001 0.0599 
Score == Arterial Stiffuess Score; Overweight = BMI > 25; categorical variables are presented as counts (row %); 
p-value determined by Chi-square. 
Table 4. Odds Ratios and 95% Confidence Intervals for Cardiovascular 
Disease (CVD) outcomes by Arterial Stiffness Score 
Crude Model Adjusted Model § 
CVD Outcomes by 
Arterial Stiffness Score Odds Ratio (95% CI) Odds Ratio (95% CI) 
Hypertension 
1 1.98 (1.02, 3.83) 1.02 (0.47, 10.33) 
2 7.30 (2.57, 20.74) 3.25 (1.02, 5.83) 
3 4.57 (1.66, 12.57) 1.88 (0.61, 1.10) 
0 1.0 1.0 
Hypercho lestero lemia 
1 0.96 (0.49, 1.85) 0.64 (0.30, 1.37) 
2 0.62 (0.25, 1.54) 0.36 (0.13, 1.03) 
3 2.15 (0.83, 5.53) 1.36 (0.47, 3.94) 
0 1.0 1.0 
End Organ Damage 
1 1.60 (0.80, 3.18) 1.09 (0.50, 2.36) 
2 8.27 (3.06,22.36) 4.92 (1.66, 14.59) 
3 2.37 (0.93, 6.07) 1.32 (0.46, 3.82) 
0 1.0 1.0 
Overweight 
1 0.51 (0.25, 1.04) 0.47 (0.21, 1.05) 
2 0.43 (0.18, 1.06) 0.44 (0.16, 1.25) 
3 0.38 (0.15, 0.98) 0.38 (0.12, 1.15) 
0 1.0 1.0 
Reference grQUp = score of zero; Overweight = BMI > 25: § Adjusted for Age, Gender, Race 
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The three different indicators of arterial compliance had similar factors associated 
with the measurements. Likewise, the associations with disease outcomes were similar 
for the three measures. The arterial stiffness score summing the highest risk group was 
associated with the highest disease risk. These results identify one of the three 
assessments of arterial stiffness are associated with increased disease risks. However, the 
analyses failed to identify anyone of the three measures as superior in predicating 
disease. As the three indicators were determined from one measurement, each marker 
should be correlated. 
This study was a hypothesis driving study to assess cardiovascular disease risk 
factors, especially hypertension and end organ damage in a local population cohort with 
varying disease states. The results from this study suggest that this noninvasive screening 
method could potentially be used in the clinical setting as an alternative diagnostic tool in 
regards to cardiovascular health. Pulse contour analysis should be further studied in a 
true clinical setting to examine the diagnostic and economical benefits of this noninvasive 
screening method. Future longitudinal studies are needed to determine if SAEI or LAEI 
is an independent predictor of CVD. This study allowed me to gain knowledge in 
cardiovascular disease health, especially in hypertension. I plan to continue my 
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Appendix A - Preliminary Study Sample Size 
With a sample size of 226, approximately 19 and 107 subjects per group are 
needed for a two-sample, two-sided .10 significance level at a power of 80% with an 
effect size of 0.600 to detect an approximate 3 ml/mmHg clinically important difference 
(as reported in Woodman et al) in large arterial elasticity, Cl assuming a standard 
deviation of5.0. Approximately 29 and 197 subjects per group are required for a two-
sample, two-sided 0.10 significance level at a power of 80% with an effect size of 0.500 
to detect an approximate 2 ml/mmHg clinically important difference (as reported in 
Woodman et al) in small arterial elasticity, C2 assuming a standard deviation of 4.0. 
Refer to Table B for sample size calculations. 
Table B: Two group t-test of equal means (unequal n's) 
Test significance level, a 
1 or 2 sided test? 
Group 1 mean, m) 
Group 2 meao, ml 
Difference in means, m1 - m2 
Common staodard deviation, s 
Effect size, d = Imt - m21 / s 
Power ( %) 
D:z 
Ratio: 02/ nl 















Appendix B - Preliminary Studies 
CDC Wonder was utilized to determine the mortality rate of hypertension based 
in the state of South Carolina from 1999-2003. The lCD-iO code used to identify 
hypertensive diseases were HIIO-HII3, which includes essential hypertensive diseases, 
hypertensive heart disease, and hypertensive renal disease. Results were grouped by race. 
All genders, ages, races, and urbanizations were included. Rates were standardized to the 
2000 US population. Age Adjusted Rates and Crude Rates Per 100,000 for all of the 
South Carolina counties, grouped by race (i.e. White, Other, Black or African American) 
are shown in Table A. The counts of the disease by race are also shown in Table A. 
Maps 1,2 and 3 display the same infonnation geographically, grouped by county. The 
Age Adjusted Rates per 100,000 for Black or African American in South Carolina is 
41.5, Whites is 13.1, and Other 1.7 (may be unreliable). The mortality rates of Blacks 
(African American) due to hypertension related diseases are drastically higher in South 
Carolina as compared to White and Other Races groups. As compared to the US 
mortality rate due to hypertension, South Carolina falls in the 36.8 to 44.7 per 100,000 
range, which is considerably higher as compared to other states in the US. The most 
concentrated areas of mortality due to hypertension seem to be located in the southeastern 
regions including considerably higher rates from Georgia, Florida, to Texas. Maps 4, 5, 
and 6 display the Age Adjusted Rates for the US population for comparison to SC rates. 
(CDC Wonder, 2007). 
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T bl A A Ad· t d d CdR t 100000· SC db R a e . ·I~e IJUS e an ru e a es per In groul!e .y ace . , 
Race State Count Population Crude Rate Age Adj usted Rate 
per 100,000 per 100,000 
White SC (45) 1,888 13,941,393 13.5 13.1 
Black! AA SC (45) 1,851 6,066,453 30.5 41.5 
Other SC (45) 4 294,649 1.4* 1.7* 
*Number may be unrehable accordmg to CDC Wonder 
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Map 1: Counts by county for White Hypertensives in SC 
Count for South Carolina 
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Map 3: Counts by county for Other Race Hypertensives in South Carolina 
Count for South Carolina 
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Map 4: Age Adjusted Rates per 100,000 for White Hypertensives in the US 
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Appendix C - Subset Cobort Data 
Subset Study Population: 
A subset of76 subjects had 25m! serum blood samples collected for a lipid profile 
to measure total cholesterol, LDL, HDL, white blood cell count (WBe), 
hemoglobinA1C, fibrinogen, triglyceride levels. All blood samples test were completed 
by MUSe, General Clinical Research Center (GCRC). 
Results: 
When examining the subset of subjects with blood sample analysis age, 
Hemoglobin Ale, High LDL greater than 160, HDL, Fibrinogen, and elevated fibrinogen 
above 300 was significantly correlated with arterial stiffness score (p-value <0.10); 
however, there was no association present with the various disease states in this subset 
population. Diabetes, kidney disease, and low HDL below 40 were significantly 
associated with arterial stiffness score (Table C). 
Discussion: 
In the subset population with lipid profiles, we found that Hemoglobin Ale, LDL 
above 160, HDL, and Fibrinogen above 300 was statistically associated with Arterial 
Stiffness Score, and could possibly be a another predictor of vessel disease and 
atherosclerosis diagnoses. Fasting glucose has been shown to be highly associated with 
arterial stiffness, proportionately with level of blood glucose, even among normal healthy 
subjects. Hyperglycemia is a common factor for both Type 1 and Type 2 diabetic 
individuals!! and has been shown to be associated with an increase in arterial stiffness 
when compared to non-diabetic individuals, even though many other factors including 
disease duration and degree of therapy control are thought to influence this affect as well 
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(Lehmann, ED, et ai, 1992). In vitro studies have shown a link between arterial stiffness 
and hypercholesterolemia along with clinical studies suggesting a significant positive 
correlation between cholesterol and low-density lipoprotein cholesterol (LDL), and a 
negative correlation with high-density lipoprotein cholesterol (HDL) with arterial 
stiffness. Familial hypercholesterolemia has also been shown to be associated with the 
stiffening of the arterial wall; which implies possible genetic and environmental 
components may play an essential role in the development of arterial stiffness and 
atherosclerosis (Cheng, HM, 2007). 
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Table CO' Summary Statistics for blood samples (N=76) 
Total 
Population Pearson's P CHI-SQ 
Parameters N=76 value P value 
Arterial Stiffness Score (1-3) 45 (59%) 
Age 57.1 ± 12.7 <.0001 
Gender (male) 38 (50%) 0.1539 0.1350 
Race (white) 66 (87%) 0.6810 0.9124 
Hypertension 32 (42%) 0.1114 0.2271 
Diabetes 10 (13%) 0.2387 0.0652 
H~ercholesterolemia 31(41%) 0.3782 0.8119 
M~ocardial Infarction 6 (8%) 0.4889 0.2834 
Stroke 6 (80/0J 0.4889 0.2834 
Heart disease 12 (16%) 0.3051 0.1518 
Kidne~roblems 8 (11%) 0.5958 0.0343 
Blood clots 3 (4%) 0.8824 0.3026 
Overweight (BMI >25) 54 (710/0) 0.2573 0.4136 
HbAIC 5.53 ± 0.67 0.0922 
High HbAIC 4 (5%) 0.7156 0.2008 
Total Cholesterol 193.88 ± 42.7 0.1259 
High Total Cholesterol 13 (17%) 0.1383 0.3690 
LDL 118.42 ± 37.8 0.3047 
High LDL 12 (16%) 0.0673 0.1815 
HDL 46.71 ± 15.6 0.0454 
LowHDL 29 (39%) 0.1083 0.0737 
Tri~!ycerides 149.03 ± 103.2 0.3697 
High Triglycerides 14 (19%) 0.7946 0.4120 
Fibrinogen 354.58 ± 79.0 0.0338 
Elevated Fibrinogen 62 (82%) 0.0758 0.2168 
'" Data are expressed as frequencies for categorical variables and means ± standard 
deviation for continuous variables~ HbAIC - Hemoglobin Ale; High HbA1C;:: 7~ High 
Total Cholesterol ~ 240~ High LDL ~ 160; Low HDL < 40~ High Triglycerides ~ 200~ 
Elevated Fibrinogen ~ 300; Zero Smokers in Subset~oup. 
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Appendix D - Health Survey 
HEAL TH INTERVIEW 




Date of last periodontal exam I 1 ___ _ 
What is your birth date? I 1 ___ _ 
Height Weight ______ _ 
How would you best describe your racial identity? Circle all that apply. 
White Black Hispanic Asian Other 
How many times a week do you exercise? 
How many times a day do you brush your teeth? 
How many times a day do you use dental floss? 
When was your last visit to a dentist? Month Y ear_~ __ 
Do you have a regular dentist or dental clinic? YES NO 
Has a dentist ever told you that you have gum disease, periodontitis, or gingivitis? 
YES NO DON'T KNOW 
Have you ever undergone any treatment for gum disease? 
YES NO DON'T KNOW 
IF YES -:) Treatments done 
Have you smoked at least 100 cigarettes in your lifetime? YES NO 
On average, about how many cigarettes a day DOIDID you smoke? 
How many years have you smoked? _____ _ 
Have you used chewing tobacco or snuff, such as Redman, Beechnut, Copenhagen, or 
Skoal, at least 20 times? YES NO 
On average, about how many times a day DOIDID you use snuff or chewing tobacco? 
What is the usual number of alcoholic beverages you HA VEIHAD per week? 
How long ago was your last cup of coffee/tealcaffeinated beverage? 
Have you ever had a HEART ATTACK? 
YES NO DON'T KNOW 
IF YES-7 How many times? 
How long ago? 
Have you ever had a STROKE? 
YES NO DON'T KNOW 
IF YES -7 How many times? 
How long ago? 
Do you use aspirin on a regular basis? YES NO DON'T KNOW 
YES -7 How many days a week are you taking aspirin? 
What dosage do you take? mg 
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Has a doctor ever told you that you had any of the following: 
Heart Disease YES NO 
Kidney Problems YES NO 
IF YES~List? 
Rheumatic fever, faulty 
heart valve, or heart murmur? 
Blood clots in the lung or 
in the leg veins? 
Artificial joint replacement? 
Which joint and date of most recent surgery? 
High Blood Pressure or Hypertension? 
IF YES: 
Are you taking medicine for this? 
IF YES~Names ifknown? 
High Blood Cholesterol 
IF YES: 
Are you taking medicine for this? 
IF YES-7Names ifknown? 
Diabetes 
IF YES: 





















IF YES 7- Insulin or Pills: 
Was insulin your frrst diabetes medicine? 
FOR WOMEN: 
-----
YES NO DON'T KNOW 
Did diabetes occur only during pregnancy? YES NO DON'T KNOW 
What medications andlor supplements are you currently taking? 
What is the highest degree or level of school you have completed? 
No Schooling Technical School Certificate 
Grades 1-8 Associate degree (Junior College, e.g. AA, AS) 
Grades 9-11 Bachelor's degree (e.g. BA, AB, BS) 
Completed high school Graduate or professional school 
Some college but no degree 
Are you currently employed outside the home? 
Are you retired? 





On this sheet is a list of income groups. Please circle which group best represents your 
total combined family income for the past 12 months. This includes the total income 
before taxes earned in the past ear by all family members living with you. Please include 
money from jobs, net income from business, farm or rent, pensions, dividends, welfare, 
50 
social security payments and any other money received by you or any other family 
member living with you .. 
Less than 5,000 16,OOO-19~999 35,000-39,999 100,000 or more 
5,000-7,999 20,000-24,999 40,000-49,999 
8,000-11,999 25,000-29,999 50,000-74,999 
12,000-15,999 30,000-34,999 75,000-99,999 
To help pay for your medical care, do you now have: (circle all that apply) 
HMO or other private insurance such as Blue Cross, Aetna, 1199 Fund, etc. 
Medicare 
Medicaid 




Health Interview Survey designed by Dr Amal Rastogi. 
I I ------
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Appendix E - IRB Approval 
This study was approved for Exempt Research/Quality Assessment Review by 
Muse Institutional Review Board on 12/13/2007. HR number 17855. Expiration Date 
12/13/2012. 
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